Cambridge, United Kingdom

Nicolas James Walker

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Biomodal Limited, Cambridge Epigenetix Limited. Active years: 2023-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Nicolas James Walker in Nucleic Acid Analysis

Introduction

Nicolas James Walker is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of nucleic acid analysis, particularly through his innovative methods and systems. His work is essential for advancing genetic research and diagnostics.

Latest Patents

Nicolas James Walker holds a patent for "Methods for analyzing nucleic acids." This patent provides methods, systems, and compositions for determining a base in a polynucleotide. The techniques presented are particularly useful for performing 4-base, 5-base, or 6-base sequencing of polynucleotide molecules, including those derived from liquid biopsy samples or low-frequency mutations.

Career Highlights

Walker is associated with Cambridge Epigenetix Limited, where he applies his expertise in nucleic acid analysis. His work at the company has positioned him as a key figure in the development of innovative solutions for genetic sequencing.

Collaborations

Some of his notable coworkers include Shankar Balasubramanian and Jens Fullgrabe. Their collaborative efforts contribute to the advancement of research in the field of epigenetics and nucleic acid analysis.

Conclusion

Nicolas James Walker's contributions to nucleic acid analysis through his patent and work at Cambridge Epigenetix Limited highlight his role as an influential inventor in the field. His innovations are paving the way for future advancements in genetic research and diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…